Last reviewed · How we verify

NCT03932734

Patient Satisfaction After Patient-specific Jawline Augmentation

Status unknown Last updated 30 July 2019
What this trial tests

trial testing survey in Congenital Deformity of Face in 26 participants. Status unknown.

Timeline
30 June 2019
Primary endpoint
1 December 2019
31 January 2020

Quick facts

Lead sponsorUniversitair Ziekenhuis Brussel
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment26
Start date30 June 2019
Primary completion1 December 2019
Estimated completion31 January 2020
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Universitair Ziekenhuis Brussel — full company profile →

Who can join

Adults 18 to 75, any sex, with Congenital Deformity of Face or Post-traumatic Deformity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The survey studies patient satisfaction after titanium patient specific jawline augmentation in congenital, post-trauma, deformity and transgender/cosmetic jaw angle/border deficiencies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of survey

Trials testing the same drug.

Other Universitair Ziekenhuis Brussel trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03932734.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing